Analyst Ratings For IDEXX Laboratories (NASDAQ:IDXX)
Today, Stifel Nicolaus reiterated its Buy rating on IDEXX Laboratories (NASDAQ:IDXX) with a price target of $185.00.
There are 2 sell ratings, 2 hold ratings, 3 buy ratings on the stock.
The current consensus rating on IDEXX Laboratories (NASDAQ:IDXX) is Hold (Score: 2.14) with a consensus target price of $170.75 per share, a potential 10.39% upside.
Some recent analyst ratings include
- 8/2/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 7/28/2017-CL King Upgrade from a “Neutral ” rating to a ” Buy” rating.
- 6/13/2017-Canaccord Genuity Reiterated Rating of Buy.
- 5/31/2017-Aegis initiated coverage with a Sell rating.
- 2/3/2017-Feltl & Co. was Downgraded by analysts at Feltl & Co. from a “Hold ” rating to a ” Sell” rating.
- 9/29/2016-Bank of America Corporation Reiterated Rating of Neutral.
- 8/3/2016-Northcoast Research Upgrade from a “Sell ” rating to a ” Neutral” rating.
Recent Insider Trading Activity For IDEXX Laboratories (NASDAQ:IDXX)
IDEXX Laboratories (NASDAQ:IDXX) has insider ownership of 2.77% and institutional ownership of 89.12%.
- On 5/31/2017 Giovani Twigge, Insider, sold 2,572 with an average share price of $166.90 per share and the total transaction amounting to $429,266.80. View SEC Filing
- On 5/30/2017 Jonathan W Ayers, Chairman, sold 13,000 with an average share price of $167.82 per share and the total transaction amounting to $2,181,660.00. View SEC Filing
- On 5/22/2017 William T End, Director, sold 5,000 with an average share price of $162.55 per share and the total transaction amounting to $812,750.00. View SEC Filing
- On 5/10/2017 Jonathan W Ayers, Chairman, sold 27,000 with an average share price of $162.69 per share and the total transaction amounting to $4,392,630.00. View SEC Filing
- On 5/5/2017 Jonathan W. Ayers, Chairman, sold 26,000 with an average share price of $160.61 per share and the total transaction amounting to $4,175,860.00. View SEC Filing
- On 5/4/2017 Rebecca M Henderson, Director, sold 1,700 with an average share price of $159.95 per share and the total transaction amounting to $271,915.00. View SEC Filing
- On 3/1/2017 Lawrence D Kingsley, Director, bought 1,000 with an average share price of $146.48 per share and the total transaction amounting to $146,480.00. View SEC Filing
Recent Trading Activity for IDEXX Laboratories (NASDAQ:IDXX)
Shares of IDEXX Laboratories closed the previous trading session at 154.67 down -0.01 -0.01% with 1,380,335 shares trading hands.